Paul I. Wen de Bakker (born 1973) is a Dutch bioinformatician who specializes in computational biology and genetic epidemiology. He has been Senior Director of Computational Genomics at Vertex Pharmaceuticals since 2015. He previously worked at Harvard Medical School from 2007 to 2012, and served as Professor of Genetic Epidemiology and Bioinformatics at the University of Utrecht from 2012 to 2015.[3] He is known for his research on the genetics of innate resistance to HIV.[4][5][6]
Paul de Bakker | |
|---|---|
| Born | Paul I. Wen de Bakker 24 August 1973 [2] |
| Nationality | Dutch |
| Education | University of Bristol Utrecht University University of Cambridge |
| Known for | Computational genomics |
| Scientific career | |
| Fields | Computational biology Genetic epidemiology |
| Institutions | Harvard Medical School (2007–2012) University of Utrecht (2012–2015) Vertex Pharmaceuticals (2015–present) |
| Thesis | Ab initio sampling of polypeptide conformations and the prediction of protein structure (2003) |
| Doctoral advisor | Tom Blundell[1] |
References
edit- ^ "Paul de Bakker". Paul de Bakker Lab. Retrieved 2018-12-31.
- ^ ProfessorProf.dr. P.I.W. de Bakker (1973 - ) at the Catalogus Professorum of the University of Utrecht
- ^ "News". McCammon Group. Retrieved 2018-12-31.
- ^ Heisler, Gregory (2009-01-15). "The Rare Few". Proto Magazine. Retrieved 2018-12-31.
- ^ Finkel, Elizabeth (2012). The Genome Generation. Melbourne Univ. Publishing. pp. 141–3. ISBN 9780522856477.
- ^ Davis, Daniel Michael (2014). The Compatibility Gene: How Our Bodies Fight Disease, Attract Others, and Define Our Selves. Oxford University Press. p. 92. ISBN 9780199316410.
External links
edit- Paul de Bakker publications indexed by Google Scholar
 | This article about a geneticist or evolutionary biologist is a stub. You can help Wikipedia by expanding it. |